We are live on ! Find out more
IMVT icon

Immunovant
IMVT

94 hedge funds and large institutions have $157M invested in Immunovant in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 31 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

299% more call options, than puts

Call options by funds: $2.51M | Put options by funds: $629K

0.46% more ownership

Funds ownership: 33.98% → 34.45% (+0.46%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 31

16% less funds holding

Funds holding: 112 → 94 (-18)

21% less capital invested

Capital invested by funds: $197M → $157M (-$40.5M)

54% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 26

Holders
94
Holders Change
-18
Holders Change %
-16.07%
% of All Funds
1.58%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
31
Reduced
31
Closed
26
Calls
$2.51M
Puts
$629K
Net Calls
+$1.88M
Net Calls Change
-$4.46M

Top Buyers

1
DTC
Deep Track Capital
Connecticut
+$9.63M
2
AGM
Alpine Global Management
New York
+$2.53M
3
BlackRock
BlackRock
New York
+$1.2M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.01M

Top Sellers

1
OCA
Octagon Capital Advisors
New York
-$3.87M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.53M
3
MP
Mangrove Partners
Connecticut
-$2.03M
4
PAMP
Polar Asset Management Partners
Ontario, Canada
-$1.92M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
DTC
1
Deep Track Capital
Connecticut
$36.9M +$9.63M +2,230,387 +31%
EAM
2
Eventide Asset Management
Massachusetts
$21M – – –
AGM
3
Alpine Global Management
New York
$17.3M +$2.53M +586,228 +15%
Vanguard Group
4
Vanguard Group
Pennsylvania
$15.6M +$1.01M +233,780 +6%
BlackRock
5
BlackRock
New York
$14.2M +$1.2M +277,444 +8%
Federated Hermes
6
Federated Hermes
Pennsylvania
$7.34M -$93.1K -21,543 -1%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$3.69M +$1.1M +254,515 +37%
State Street
8
State Street
Massachusetts
$3.48M +$246K +56,938 +7%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$3.1M +$26.5K +6,134 +0.8%
PIM
10
Platinum Investment Management
Australia
$3.03M +$393K +90,930 +13%
JP Morgan Chase
11
JP Morgan Chase
New York
$2.55M +$828K +191,599 +42%
FLSM
12
Frazier Life Sciences Management
California
$2.28M – – –
OCA
13
Octagon Capital Advisors
New York
$2.26M -$3.87M -895,939 -61%
Two Sigma Investments
14
Two Sigma Investments
New York
$2.15M -$1.17M -271,486 -33%
Two Sigma Advisers
15
Two Sigma Advisers
New York
$2.11M -$737K -170,600 -24%
Northern Trust
16
Northern Trust
Illinois
$1.39M -$48.6K -11,245 -3%
Millennium Management
17
Millennium Management
New York
$1.3M -$1.13M -262,727 -44%
Renaissance Technologies
18
Renaissance Technologies
New York
$1.3M +$1M +231,900 +230%
ECM
19
ExodusPoint Capital Management
New York
$1.22M +$66K +15,286 +5%
Charles Schwab
20
Charles Schwab
California
$1.19M +$30.3K +7,017 +2%
Goldman Sachs
21
Goldman Sachs
New York
$955K -$478K -110,742 -31%
HWAM
22
Hennion & Walsh Asset Management
New Jersey
$920K +$64.2K +14,861 +7%
State of Wisconsin Investment Board
23
State of Wisconsin Investment Board
Wisconsin
$877K +$379K +87,667 +64%
N
24
Nuveen
North Carolina
$708K -$180K -41,568 -19%
WIM
25
Wittenberg Investment Management
Massachusetts
$679K +$145K +33,500 +24%
1
2 3 4 5

IMVT Hedge Fund Activity: Q2 2022 in Review

94 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q2 2022, worth a combined $157M — down 21% from $197M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of IMVT and 12 opened new positions — a net loss of 14 holders — while 31 trimmed existing stakes and 31 added.

The largest buyer was Deep Track Capital, adding an estimated $9.63M. The largest seller was Octagon Capital Advisors, cutting an estimated $3.87M.

  • 94 institutional investors held Immunovant (IMVT) as of Q2 2022, down from 112 in Q1 2022.
  • Funds reported $157M of Immunovant stock for Q2 2022, down 21% quarter-over-quarter.
  • 12 funds opened new Immunovant positions in Q2 2022 and 26 closed out, a net change of -14 holders.
  • The largest Immunovant buyer in Q2 2022 was Deep Track Capital, an estimated $9.63M added.
  • The largest Immunovant seller in Q2 2022 was Octagon Capital Advisors, an estimated $3.87M sold.

Based on aggregated 13F filings for Q2 2022.